MANUFACTURERS LIFE INSURANCE COMPANY, THE - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$9,695,222
-87.3%
357,230
-85.7%
0.01%
-86.0%
Q2 2023$76,555,326
-23.5%
2,490,414
-10.4%
0.04%
-24.6%
Q1 2023$100,115,120
+26.9%
2,778,660
+39.2%
0.06%
+14.0%
Q4 2022$78,901,202
-17.9%
1,996,437
-16.5%
0.05%
-25.4%
Q3 2022$96,118,010
+963.1%
2,391,857
+1012.7%
0.07%
+1016.7%
Q2 2022$9,041,023
+34.6%
214,953
+24.8%
0.01%
+50.0%
Q1 2022$6,716,766
+1522.4%
172,238
+1559.2%
0.00%
Q4 2021$414,000
+10.4%
10,3810.0%0.00%
Q3 2021$375,000
-93.2%
10,381
-92.3%
0.00%
-100.0%
Q2 2021$5,525,000
-34.5%
134,781
-30.3%
0.00%
-42.9%
Q1 2021$8,436,000
-18.7%
193,389
-6.7%
0.01%
-30.0%
Q4 2020$10,379,000
+33.6%
207,355
+12.3%
0.01%
+25.0%
Q3 2020$7,767,000
-18.1%
184,621
-14.6%
0.01%
-11.1%
Q2 2020$9,489,000216,1450.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2020
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders